Try searching for...
Dr Vanessa Estall
BHB, MBChB, FRANZCR, MD
For patients/carers
For doctors
BHB, MBChB, FRANZCR, MD
Locations
Clinical interests
- Colorectal (bowel) cancer
- Brain and central nervous system
- Skin cancer
Treatment techniques
- External beam radiation therapy (EBRT)
- Volumetric modulated arc therapy (VMAT)
- Stereotactic radiosurgery (SRS)
Languages
Fluent
- English
Biography
Clinical interest in skin/melanoma, head and neck, CNS, lung, lymphoma and palliative radiation therapy.
Dr Vanessa Estall is an empathetic, experienced clinician, with a focus on evidence-based practice. She completed specialist Radiation Oncology training in Australia in 2007, and a Research Fellowship at Addenbrookes Hospital Cambridge UK in 2009. Her work assessed the highly precise and novel radiation treatment for skull base tumours, and she was awarded a Doctorate of Medicine (MD).
She has since worked in large treatment centres in NSW and Victoria, gaining specialist skills in stereotactic radiosurgery, Skin/Melanoma, Central Nervous System (CNS), Head and Neck, and Lung cancers and palliative care radiotherapy.
She is active in research, teaching, quality assurance, governance, and leadership. She has led multiple multidisciplinary clinical teams, is a clinical supervisor in the training of future radiation oncologists and has held leadership positions in the Royal Australian and New Zealand College of Radiology (RANZCR) including Chief Accreditation Officer for Specialist Training (2018-2023).
More information
- Glioma imaging
- Skull base tumours
- Skin/melanoma
- Head and Neck
- European Society of Radiation Oncology (ESTRO)
- Trans-Tasman Radiation Oncology Group (TROG)
- Bucknell, N., Gyorki, D., Bressel, M., Estall, V., Webb, A., Henderson, M., Chua, M., Rischin, D., & Tiong, A. (2021). Cutaneous squamous cell carcinoma metastatic to axilla and groin: Outcomes and prognostic factors. Australasian Journal of Dermatology, 63(1), 43-52.
- Wang, W., Smith, J. L., Carlino, M. S., Burmeister, B., Pinkham, M. B., Fogarty, G. B., Christie, D., Estall, V., Shackleton, M., Clements, A., Wolfe, R., Thao, L., Paton, E. J., Steel, V., & Williams, N. C. (2024). Phase I/II trial of concurrent extracranial palliative radiation therapy with dabrafenib and trametinib in metastatic BRAF V600E/K mutation-positive cutaneous melanoma. Clinical and Translational Radiation Oncology, 30, 95–99.
- Wang, T. W., Smith, L. J., Carlino, M., Burmeister, B., Pinkham, M. B., Fogarty, G. B., Christie, D., Estall, V., Shackleton, M., Wolfe, R., Phuong, T. L. T., Paton, E. J., Steel, V., & Williams, N. C. (2020). Evaluating the safety and tolerability of the combination of dabrafenib, trametinib and palliative radiotherapy in patients with metastatic BRAF V600E/K mutation-positive cutaneous melanoma. International Journal of Radiation Oncology, Biology, Physics, 108(3), S133–S134.
- Slape, D. R., Saunderson, R. B., Tatian, A. H., Forstner, D. F., & Estall, V. J. (2019). Cutaneous malignancies in Indigenous peoples of urban Sydney. Journal of Medical Imaging and Radiation Oncology, 63(2), 244–249.
- Sood, A., Wykes, J., Roshan, D., Wang, L. Y., McGuinness, J., Forstner, D., Fowler, A., Lee, M., Kernohan, M., Ngo, Q., Estall, V., & Ebrahimi, A. (2019). Number of nodal metastases and prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck. ANZ Journal of Surgery, 89(7–8), 863–867.
